These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 7781147

  • 1. The effects of oral 4-hydroxyandrostenedione on peripheral aromatisation in post-menopausal breast cancer patients.
    MacNeill FA, Jacobs S, Dowsett M, Lonning PE, Powles TJ.
    Cancer Chemother Pharmacol; 1995; 36(3):249-54. PubMed ID: 7781147
    [Abstract] [Full Text] [Related]

  • 2. Combined treatment with 4-hydroxyandrostenedione and aminoglutethimide: effects on aromatase inhibition and oestrogen suppression.
    MacNeill FA, Jacobs S, Lønning PE, Powles TJ, Dowsett M.
    Br J Cancer; 1994 Jun; 69(6):1171-5. PubMed ID: 8198987
    [Abstract] [Full Text] [Related]

  • 3. The influence of intramuscular 4-hydroxyandrostenedione on peripheral aromatisation in breast cancer patients.
    Jones AL, MacNeill F, Jacobs S, Lonning PE, Dowsett M, Powles TJ.
    Eur J Cancer; 1992 Jun; 28A(10):1712-6. PubMed ID: 1389491
    [Abstract] [Full Text] [Related]

  • 4. The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer.
    Stein RC, Dowsett M, Hedley A, Gazet JC, Ford HT, Coombes RC.
    Br J Cancer; 1990 Oct; 62(4):679-83. PubMed ID: 2145964
    [Abstract] [Full Text] [Related]

  • 5. An endocrine and pharmacokinetic study of four oral doses of formestane in postmenopausal breast cancer patients.
    Dowsett M, Mehta A, King N, Smith IE, Powles TJ, Stein RC, Coombes RC.
    Eur J Cancer; 1992 Oct; 28(2-3):415-20. PubMed ID: 1591054
    [Abstract] [Full Text] [Related]

  • 6. A randomised comparison of oestrogen suppression with anastrozole and formestane in postmenopausal patients with advanced breast cancer.
    Kleeberg UR, Dowsett M, Carrion RP, Dodwell DJ, Vorobiof DA, Aparicio LA, Robertson JF.
    Oncology; 1997 Oct; 54 Suppl 2():19-22. PubMed ID: 9394856
    [Abstract] [Full Text] [Related]

  • 7. Premenopausal breast cancer patients treated with a gonadotropin-releasing hormone analog alone or in combination with an aromatase inhibitor: a comparative endocrine study.
    Celio L, Martinetti A, Ferrari L, Buzzoni R, Mariani L, Miceli R, Seregni E, Procopio G, Cassata A, Bombardieri E, Bajetta E.
    Anticancer Res; 1999 Oct; 19(3B):2261-8. PubMed ID: 10472341
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Formestane: an effective first-line endocrine treatment for advanced breast cancer.
    Zilembo N, Bajetta E, Noberasco C, Buzzoni R, Vicario G, Bono A, Laffranchi A, Biasi G, Dolci S, Bichisao E.
    J Cancer Res Clin Oncol; 1995 Oct; 121(6):378-82. PubMed ID: 7797604
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse: endocrine and clinical results. The Italian Trials in Medical Oncology (I.T.M.O.) group.
    Bajetta E, Zilembo N, Barni S, Noberasco C, Martinetti A, Ferrari L, Schieppati G, Buzzoni R, Jirillo A, Amichetti M, D'Aprile M, Comella G, Bichisao E, Bolelli GF, Attili A, Bombardieri E.
    Ann Oncol; 1997 Jul; 8(7):649-54. PubMed ID: 9296217
    [Abstract] [Full Text] [Related]

  • 15. Dose-related endocrine effects and pharmacokinetics of oral and intramuscular 4-hydroxyandrostenedione in postmenopausal breast cancer patients.
    Dowsett M, Cunningham DC, Stein RC, Evans S, Dehennin L, Hedley A, Coombes RC.
    Cancer Res; 1989 Mar 01; 49(5):1306-12. PubMed ID: 2917360
    [Abstract] [Full Text] [Related]

  • 16. The influence of aminoglutethimide and its analogue rogletimide on peripheral aromatisation in breast cancer.
    MacNeill FA, Jones AL, Jacobs S, Lønning PE, Powles TJ, Dowsett M.
    Br J Cancer; 1992 Oct 01; 66(4):692-7. PubMed ID: 1419608
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.